Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00215137 · ClinicalTrials.gov registry record · Phase 2
Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT00215137 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 14 participants.
The verdict
NCT00215137, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study will determine the safety and effectiveness of escitalopram (Lexapro)in treating obsessive-compulsive disorder (OCD) symptoms.
Interventions
- DRUG escitalopram
- DRUG Placebo ( sugar pill)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2004-10 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00215137
The ClinicalTrials.gov registry entry for NCT00215137 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which escitalopram is the first listed.
NCT00215137 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00215137 about?
NCT00215137 is a clinical study titled "Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder". This study will determine the safety and effectiveness of escitalopram (Lexapro)in treating obsessive-compulsive disorder (OCD) symptoms.
What is the current status of trial NCT00215137?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2004-10. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00215137?
The interventions under investigation include: escitalopram (DRUG), Placebo ( sugar pill) (DRUG).
Who is sponsoring clinical trial NCT00215137?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.